ArticleOncoTargets and therapy2019

lncRNA KCNQ1OT1 enhances the chemoresistance of oxaliplatin in colon cancer by targeting the miR-34a/ATG4B pathway.

Yongchao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.